Cellectis will participate in six healthcare investor conferences from September to November
The Paris-based biotechnology laboratory has detailed its program of participation in a series of meetings with the financial community, scheduled between September and November 2026 in the United States and London.
This corporate communication is part of the company's investor relations activities, listed on Euronext Growth and Nasdaq.
Five healthcare conferences scheduled from September to November
Cellectis announced on September 1, 2026 its participation in several investor conferences dedicated to the healthcare sector.
The calendar includes the Wells Fargo 21st Annual Healthcare Conference in Boston on September 10, 2026, the Baird 2026 Global Healthcare Conference in New York on September 15, 2026 (with a company presentation from 12:50 p.m. to 1:20 p.m., Eastern Time), the Fall Focus: Barclays Biotech 1x1 Day in New York on October 6, 2026, the Stifel 2026 Healthcare Conference in New York from November 10 to 12, 2026 and the Jefferies Global Healthcare Conference in London from November 16 to 19, 2026.
Investor meetings and online webcasts
Cellectis' management team will be available for meetings with investors during these conferences, with meeting requests able to be directed to conference representatives or the company's investor relations department.
Any available webcasts will be posted on the company's website. Cellectis describes itself as a clinical-stage biotechnology company developing cell and gene therapies based on its gene editing platform, with headquarters in Paris and facilities in New York and Raleigh.
